Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal

Mintz represented ArriVent Biopharma in a $155 Million Series B financing led by Sofinnova Investments and General Catalyst to fund studies of the company's EGFR kinase inhibitor furmonertinib. Members Ed Pease and Private Equity Practice Co-Chair Matthew Simpson led the Mintz team's work on the transaction.

BOSTON – Mintz is pleased to announce that two of its attorneys have been included in Massachusetts Lawyers Weekly 2023 ‘Excellence In Law’ recognition.

SAN DIEGO – Mintz is pleased to announce that four attorneys have been named San Diego Super Lawyers and three have been recognized as Rising Stars in the 2023 edition of the annual publication.

BOSTON – Mintz’s Megan Gates, Chair of the Corporate & Securities Practice and Co-chair of the firm’s Securities & Capital Markets Practice, has been named a 2023 ‘Top Woman In Dealmaking’ as part of The Deal’s annual list. This is the third time Ms Gates has been recognized in this prestigious list.

The Bond Buyer quoted Member Charles Samuels on the House's introduction of the Investing in Our Communities bill, which would restore the provision that was eliminated by the Trump Administration.

Boston, MA – Mintz is pleased to announce that Michael T. Renaud, Chair of the Intellectual Property Division, and the firm’s International Trade Commission (ITC) Practice have been shortlisted in the 2023 edition of Managing Intellectual Property’s (MIP) Americas Awards. The awards recognize the “remarkable achievements and developments” of firms, individuals and companies impacting the IP sector over the past year.